vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Metallus Inc. (MTUS). Click either name above to swap in a different company.
Metallus Inc. is the larger business by last-quarter revenue ($267.3M vs $208.9M, roughly 1.3× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 0.5%, a 2.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 11.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $900.0K). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -4.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
IRTC vs MTUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $267.3M |
| Net Profit | $5.6M | $1.3M |
| Gross Margin | 70.9% | 2.2% |
| Operating Margin | 1.1% | — |
| Net Margin | 2.7% | 0.5% |
| Revenue YoY | 27.1% | 11.1% |
| Net Profit YoY | 518.5% | — |
| EPS (diluted) | $0.18 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $267.3M | ||
| Q4 25 | $208.9M | $267.3M | ||
| Q3 25 | $192.9M | $305.9M | ||
| Q2 25 | $186.7M | $304.6M | ||
| Q1 25 | $158.7M | $280.5M | ||
| Q4 24 | $164.3M | $240.5M | ||
| Q3 24 | $147.5M | $227.2M | ||
| Q2 24 | $148.0M | $294.7M |
| Q1 26 | — | $1.3M | ||
| Q4 25 | $5.6M | $-14.3M | ||
| Q3 25 | $-5.2M | $8.1M | ||
| Q2 25 | $-14.2M | $3.7M | ||
| Q1 25 | $-30.7M | $1.3M | ||
| Q4 24 | $-1.3M | $-21.4M | ||
| Q3 24 | $-46.2M | $-5.9M | ||
| Q2 24 | $-20.1M | $4.6M |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 70.9% | 2.2% | ||
| Q3 25 | 71.1% | 11.4% | ||
| Q2 25 | 71.2% | 10.6% | ||
| Q1 25 | 68.8% | 7.8% | ||
| Q4 24 | 70.0% | 4.5% | ||
| Q3 24 | 68.8% | 5.3% | ||
| Q2 24 | 69.9% | 8.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | -7.7% | ||
| Q3 25 | -4.4% | 3.6% | ||
| Q2 25 | -10.0% | 2.8% | ||
| Q1 25 | -20.5% | 1.0% | ||
| Q4 24 | -2.5% | -10.1% | ||
| Q3 24 | -34.1% | -3.1% | ||
| Q2 24 | -15.5% | 2.1% |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 2.7% | -5.3% | ||
| Q3 25 | -2.7% | 2.6% | ||
| Q2 25 | -7.6% | 1.2% | ||
| Q1 25 | -19.3% | 0.5% | ||
| Q4 24 | -0.8% | -8.9% | ||
| Q3 24 | -31.3% | -2.6% | ||
| Q2 24 | -13.6% | 1.6% |
| Q1 26 | — | $0.03 | ||
| Q4 25 | $0.18 | $-0.34 | ||
| Q3 25 | $-0.16 | $0.19 | ||
| Q2 25 | $-0.44 | $0.09 | ||
| Q1 25 | $-0.97 | $0.03 | ||
| Q4 24 | $-0.03 | $-0.46 | ||
| Q3 24 | $-1.48 | $-0.13 | ||
| Q2 24 | $-0.65 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $156.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $686.0M |
| Total Assets | $1.0B | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $156.7M | ||
| Q4 25 | $583.8M | $156.7M | ||
| Q3 25 | $565.2M | $191.5M | ||
| Q2 25 | $545.5M | $190.8M | ||
| Q1 25 | $520.6M | $180.3M | ||
| Q4 24 | $535.6M | $240.7M | ||
| Q3 24 | $522.0M | $254.6M | ||
| Q2 24 | $561.5M | $272.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $13.2M |
| Q1 26 | — | $686.0M | ||
| Q4 25 | $152.7M | $686.0M | ||
| Q3 25 | $121.9M | $697.7M | ||
| Q2 25 | $103.7M | $690.0M | ||
| Q1 25 | $86.7M | $686.1M | ||
| Q4 24 | $90.9M | $690.5M | ||
| Q3 24 | $71.8M | $712.7M | ||
| Q2 24 | $99.2M | $736.3M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $995.2M | $1.2B | ||
| Q2 25 | $964.0M | $1.1B | ||
| Q1 25 | $926.1M | $1.1B | ||
| Q4 24 | $931.4M | $1.1B | ||
| Q3 24 | $909.7M | $1.1B | ||
| Q2 24 | $919.2M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | — |
| Free Cash FlowOCF − Capex | $14.5M | $900.0K |
| FCF MarginFCF / Revenue | 6.9% | 0.3% |
| Capex IntensityCapex / Revenue | 5.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-25.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $26.2M | $-1.9M | ||
| Q3 25 | $34.9M | $22.0M | ||
| Q2 25 | $27.7M | $34.8M | ||
| Q1 25 | $-7.9M | $-38.9M | ||
| Q4 24 | $19.2M | $13.9M | ||
| Q3 24 | $24.3M | $-15.3M | ||
| Q2 24 | $11.8M | $8.3M |
| Q1 26 | — | $900.0K | ||
| Q4 25 | $14.5M | $-37.2M | ||
| Q3 25 | $20.1M | $-6.4M | ||
| Q2 25 | $17.3M | $17.0M | ||
| Q1 25 | $-17.3M | $-66.4M | ||
| Q4 24 | $12.4M | $-1.3M | ||
| Q3 24 | $15.5M | $-32.9M | ||
| Q2 24 | $3.4M | $-5.8M |
| Q1 26 | — | 0.3% | ||
| Q4 25 | 6.9% | -13.9% | ||
| Q3 25 | 10.4% | -2.1% | ||
| Q2 25 | 9.3% | 5.6% | ||
| Q1 25 | -10.9% | -23.7% | ||
| Q4 24 | 7.5% | -0.5% | ||
| Q3 24 | 10.5% | -14.5% | ||
| Q2 24 | 2.3% | -2.0% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 5.6% | 13.2% | ||
| Q3 25 | 7.7% | 9.3% | ||
| Q2 25 | 5.6% | 5.8% | ||
| Q1 25 | 5.9% | 9.8% | ||
| Q4 24 | 4.2% | 6.3% | ||
| Q3 24 | 6.0% | 7.7% | ||
| Q2 24 | 5.7% | 4.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | 2.72× | ||
| Q2 25 | — | 9.41× | ||
| Q1 25 | — | -29.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
MTUS
Segment breakdown not available.
